SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B4 - Prospectus [Rule 424(b)(4)]:
SEC Accession No. 0001493152-24-011750
Filing Date
2024-03-28
Accepted
2024-03-28 16:18:34
Documents
10

Document Format Files

Seq Description Document Type Size
1 form424b4.htm 424B4 2108139
2 forms-1a_001.jpg GRAPHIC 3980
3 forms1-a_002.jpg GRAPHIC 18822
4 forms-1a_003.jpg GRAPHIC 18822
5 forms-1a_004.jpg GRAPHIC 6241
6 forms-1a_005.jpg GRAPHIC 7165
7 forms-1a_006.jpg GRAPHIC 18524
8 forms-1a_007.jpg GRAPHIC 15466
9 forms-1a_008.jpg GRAPHIC 11579
10 forms-1a_009.jpg GRAPHIC 12097
  Complete submission text file 0001493152-24-011750.txt   2265540
Mailing Address 455 E. MEDICAL CENTER BLVD SUITE 300 SUITE 300 HOUSTON TX 77598
Business Address 455 E. MEDICAL CENTER BLVD SUITE 300 HOUSTON TX 77598 281-671-5152
FibroBiologics, Inc. (Filer) CIK: 0001958777 (see all company filings)

IRS No.: 863329066 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B4 | Act: 33 | File No.: 333-277019 | Film No.: 24799229
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)